OMGA Omega Therapeutics Company Short-Term Debt

Omega - graphic logo of issuer OMGA

The market for programmable mRNA-based drugs is only beginning to emerge, possessing immense demand potential due to the shortage of methods for combating severe pathologies. The price action of Omega Therapeutics (OMGA) securities on GURU.Markets, where the indicator is 0.00, is based on the OEC platform, which creates reliable capital protection until a regular cash flow emerges. Omega Therapeutics is developing an epigenomic control system via OMEGA technology, which allows for the correction of genes without modifying them.

OMGA (omegatherapeutics.com) Short-Term Debt history from 07/04/2022 to 03/08/2025

Summary analytical data breakdowns for Omega Therapeutics Corp (OMGA)

- current quotes and average value forecast:
Price Chart Omega Therapeutics, Inc.|OMGA - Average Forecast Price
- market capitalization data:
Market Value Omega Therapeutics, Inc.|OMGA - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Omega Therapeutics|OMGA - Total Stockholders' Equity|Market Capitalization to Book Value Ratio omegatherapeutics.com|OMGA - Company Balance Sheet Assets
- debt and liquidity data:
Total Debt to Capital Omega Therapeutics|OMGA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Omega Therapeutics|OMGA - Aggregate Debt Obligations|Debt to Book Value Omega Therapeutics, Inc.|OMGA - Amount of Long-Term Liabilities|Company Short-Term Debts Omega Therapeutics|Quick Ratio omegatherapeutics.com
- net income and valuation multiples indicators:
OMGA - Company Net Income
General company analysis:Omega Therapeutics, Inc. - OMGA
Manufactured products of omegatherapeutics.com

Short-term debt dynamics determine the liquidity of Omega Therapeutics (OMGA), which is critical for funding costly developments in epigenetics and precision genomics. By analyzing credit obligations with a maturity of up to one year, an investor assesses not only the default risk but also the business's scaling potential, as increased borrowing often serves as a tool for expansion within the behemoth market of fundamental medicine.

Who Omega Therapeutics competes with

TEM - Company Short-Term Debt|Short-Term Debt Qiagen NV|Ionis Pharma (IONS) - Company Short-Term Debt|Company Current Liabilities Repligen Inc.|RNA (Avidity Biosciences) - Company Short-Term Debts|Short-Term Debt crisprtx.com CRSP|Company Short-Term Debts WGS|Ultragenyx Pharmaceutical Inc. (RARE) - Short-Term Indebtedness|Company Short-Term Debts BEAM (Beam Therapeutics Corp)|Company Short-Term Debts Sarepta Corp SRPT|TWST: Company Current Liabilities|Company Short-Term Loans and Borrowings TXG (10xgenomics.com)|NTLA (Intellia Therapeutics, Inc.) - Company Current Liabilities|STOK: Amount of Current Liabilities|BLFS (BioLife Corp) - Company Short-Term Debts|WVE: Company Short-Term Loans and Borrowings|Company Short-Term Debts MAZE|SION - Short-Term Debt|Company Short-Term Debt Prime Medicine PRME|Company Short-Term Loans and Borrowings TSHA|uniQure Corp - Company Short-Term Debts|MGTX - Company Short-Term Debts|REGENXBIO Inc. (RGNX) - Company Short-Term Debt|Current Liabilities SLDB (solidbio.com)|OCGN (Ocugen) - Company Short-Term Debts|Short-Term Debt Pacific Biosciences of California, Inc. PACB|Company Current Liabilities BNTC (Benitec)|Company Short-Term Debts Design Corp (DSGN)|Rocket Pharmaceuticals - Company Current Liabilities|Amount of Current Liabilities FDMT (4dmoleculartherapeutics.com)|Lexeo - Company Short-Term Debts|Short-Term Debt Volume Korro Bio, Inc. KRRO|EDIT: Company Short-Term Debts|Company Current Liabilities Silence Therapeutics Corp|Company Short-Term Debt ProQR|Codexis Bio (CDXS) - Short-Term Debt Volume|Company Short-Term Debt Sangamo Therapeutics, Inc. (SGMO)|NAUT - Short-Term Debt|Company Short-Term Debt Metagenomi, Inc MGX|DTIL - Company Current Liabilities|Generation Bio Corp - Company Short-Term Debts|Short-Term Indebtedness boundlessbio.com (BOLD)|XCUR: Company Short-Term Debts|Imunon (IMNN) - Company Short-Term Debts|PHIO (Phio Pharmaceuticals Corp) - Company Short-Term Debts|Company Short-Term Indebtedness MBIO (Mustang Bio Corp)|Company Short-Term Debt TransCode Therapeutics (RNAZ)|bionanogenomics.com - Company Short-Term Indebtedness|Company Short-Term Debts APDN (Applied DNA Sciences, Inc.)|Company Short-Term Debts bluebird bio Inc. BLUE|IPA - Company Short-Term Debt|Short-Term Debt Singular Genomics Corp|Regulus Therapeutics (RGLS) - Company Short-Term Debt|Company Current Liabilities syros.com|TBIO (Telesis Bio) - Company Short-Term Debts|Short-Term Debt TRACON Pharmaceuticals Inc. TCON|Company Short-Term Debts UBX